FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Nifedipine Extended-Release Tablet, USP
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Par Pharmaceutical (New 04/15/2019)

Company Contact Information:
800-828-9393

Presentation Posting Date Related Information
30mg, 100 count bottle (NDC 10370-677-01) 04/15/2019 Par has made a business decision to permanently discontinue the drug product.
30mg, 500 count bottle (NDC 10370-677-05) 04/15/2019 Par has made a business decision to permanently discontinue the drug product.
60mg, 100 count bottle (NDC 10370-678-01) 04/15/2019 Par has made a business decision to permanently discontinue the drug product.
60mg, 500 count bottle (NDC 10370-678-05) 04/15/2019 Par has made a business decision to permanently discontinue the drug product.
90 mg, 100 count bottle (NDC 10370-679-01) 04/15/2019 Par has made a business decision to permanently discontinue the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English